{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:00:47Z","timestamp":1782907247596,"version":"3.54.5"},"reference-count":18,"publisher":"Medknow","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.11622\/smedj.2022076","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T07:17:13Z","timestamp":1657869433000},"page":"283-287","source":"Crossref","is-referenced-by-count":12,"title":["Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors"],"prefix":"10.4103","volume":"63","author":[{"given":"S","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AK","family":"Lefor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","published-online":{"date-parts":[[2022,5]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","unstructured":"1. Malfertheiner P, Kandulski A, Venerito M. Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol 2017; 14:697-710.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000500819","article-title":"Current status of Helicobacter pylori diagnosis and eradication therapy in Japan using a nationwide database","volume":"101","author":"Deguchi","year":"2020","unstructured":"2. Deguchi H, Uda A, Murakami K. Current status of Helicobacter pylori diagnosis and eradication therapy in Japan using a nationwide database. Digestion 2020; 101:441-9.","journal-title":"Digestion"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/00365521.2018.1486883","article-title":"Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan","volume":"53","author":"Shinozaki","year":"2018","unstructured":"3. Shinozaki S, Osawa H, Kobayashi Y, et al. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan. Scand J Gastroenterol 2018; 53:897-904.","journal-title":"Scand J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/apt.13588","article-title":"Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype","volume":"43","author":"Kagami","year":"2016","unstructured":"4. Kagami T, Sahara S, Ichikawa H, et al. Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype. Aliment Pharmacol Ther 2016; 43:1048-59.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/00365521.2017.1322137","article-title":"Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study","volume":"52","author":"Kiso","year":"2017","unstructured":"5. Kiso M, Ito M, Boda T, et al. Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study. Scand J Gastroenterol 2017; 52:828-32.","journal-title":"Scand J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5946\/ce.2018.104","article-title":"Magnified endoscopic findings of multiple white flat lesions: a new subtype of gastric hyperplastic polyps in the stomach","volume":"51","author":"Hasegawa","year":"2018","unstructured":"6. Hasegawa R, Yao K, Ihara S, et al. Magnified endoscopic findings of multiple white flat lesions: a new subtype of gastric hyperplastic polyps in the stomach. Clin Endosc 2018; 51:558-62.","journal-title":"Clin Endosc"},{"key":"ref6","unstructured":"7. Kamada T, Haruma K, Inoue K, Shiotani A. [Helicobacter pylori infection and endoscopic gastritis -Kyoto classification of gastritis]. Nihon Shokakibyo Gakkai Zasshi 2015; 112:982-93. Japanese."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0028-1098086","article-title":"An endoscopic recognition of the atrophic border and its significance in chronic gastritis","volume":"1","author":"Kimura","year":"1969","unstructured":"8. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1:87-97.","journal-title":"Endoscopy"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2169\/internalmedicine.9808-17","article-title":"Prevalence of multiple white and flat elevated lesions in individuals undergoing a medical checkup","volume":"57","author":"Adachi","year":"2018","unstructured":"9. Adachi K, Mishiro T, Okada M, Kinoshita Y. Prevalence of multiple white and flat elevated lesions in individuals undergoing a medical checkup. Intern Med 2018; 57:1213-8.","journal-title":"Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/den.12765","article-title":"Gastric mucosal cracked and cobblestonelike changes resulting from proton pump inhibitor use","volume":"29","author":"Miyamoto","year":"2017","unstructured":"10. Miyamoto S, Kato M, Tsuda M, et al. Gastric mucosal cracked and cobblestonelike changes resulting from proton pump inhibitor use. Dig Endosc 2017; 29:307-13.","journal-title":"Dig Endosc"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14:1706-19.e5.","DOI":"10.1016\/j.cgh.2016.05.018"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1365-2036.2006.03127.x","article-title":"Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy","volume":"24","author":"Jalving","year":"2006","unstructured":"12. Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24:1341-8.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00535-010-0207-7","article-title":"Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan","volume":"45","author":"Hongo","year":"2010","unstructured":"13. Hongo M, Fujimoto K; Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 2010; 45:618-24.","journal-title":"J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","unstructured":"14. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report. Gut 2017; 66:6-30.","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2169\/internalmedicine.9889-17","article-title":"Multiple white and flat elevated lesions observed in the stomach: a prospective study of clinical characteristics and risk factors","volume":"57","author":"Majima","year":"2018","unstructured":"15. Majima K, Muraki Y, Shimamoto T. Multiple white and flat elevated lesions observed in the stomach: a prospective study of clinical characteristics and risk factors. Intern Med 2018; 57:2613-9.","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI110818","article-title":"Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings","volume":"71","author":"Feldman","year":"1983","unstructured":"16. Feldman M, Richardson CT, Walsh JH. Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings. J Clin Invest 1983; 71:715-20.","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MCG.0000000000000542","article-title":"Study of gender differences in proton pump inhibitor dose requirements for GERD: a double-blind randomized trial","volume":"51","author":"Helgad\u00f3ttir","year":"2017","unstructured":"17. Helgad\u00f3ttir H, Metz DC, Lund SH, et al. Study of gender differences in proton pump inhibitor dose requirements for GERD: a double-blind randomized trial. J Clin Gastroenterol 2017; 51:486-93.","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.2169\/internalmedicine.7964-16","article-title":"Proton pump inhibitor induction of gastric cobblestone-like lesions in the stomach","volume":"56","author":"Takahari","year":"2017","unstructured":"18. Takahari K, Haruma K, Ohtani H, et al. Proton pump inhibitor induction of gastric cobblestone-like lesions in the stomach. Intern Med 2017; 56:2699-703.","journal-title":"Intern Med"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/changes-gastric-morphology-during-long-term-use-vonoprazan-compared-proton-pump-inhibitors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:51:42Z","timestamp":1660042302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/changes-gastric-morphology-during-long-term-use-vonoprazan-compared-proton-pump-inhibitors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2022076","relation":{},"ISSN":["0037-5675","2737-5935"],"issn-type":[{"value":"0037-5675","type":"print"},{"value":"2737-5935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}